Clinical Trials Directory

Trials / Completed

CompletedNCT00991679

CXCL9, CXCL10, CXCL11, and CXCR3 in Dry Eye Syndrome

Expression of CXCL9, CXCL10, CXCL11, and CXCR3 in the Tear Film and Ocular Surface of Patients With Dry Eye Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
48 (actual)
Sponsor
Chonnam National University Hospital · Academic / Other
Sex
All
Age
24 Years – 77 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to investigate the expression of CXCL9, CXCL10, CXCL11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome. Thirty-three patients with dry eye (16 Sjögren's syndrome and 17 non-Sjögren's syndrome patients) and 15 control subjects were recruited. The concentrations of CXCL9, CXCL10, and CXCL11 in tears were measured using enzyme-linked immunosorbent assay. The correlation between chemokine levels and tear film and ocular surface parameters was analyzed. Expression of CXCL9, CXCL10, CXCL11, and CXCR3 in the conjunctiva was evaluated using immunohistochemistry. Flow cytometry was performed to count CXCR3+ cells and CXCR3+CD4+ cells in the conjunctiva.

Conditions

Timeline

Start date
2008-02-01
Primary completion
2008-10-01
Completion
2008-12-01
First posted
2009-10-08
Last updated
2009-10-08

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT00991679. Inclusion in this directory is not an endorsement.

CXCL9, CXCL10, CXCL11, and CXCR3 in Dry Eye Syndrome (NCT00991679) · Clinical Trials Directory